Done by khozama jehad. Neoplasia of the cervix

Similar documents
CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Understanding Your Pap Test Results

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Human Papillomavirus

What is cervical cancer?

Cervical Dysplasia and HPV

Histopathology: Cervical HPV and neoplasia

Making Sense of Cervical Cancer Screening

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Colposcopy. Attila L Major, MD, PhD

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Mousa. Lina Al-Lawama. Enas Ajarma. 0 P a g e

Screening for Cervical Cancer. Grand Rounds 1/16/13 Meggan Linck

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Eradicating Mortality from Cervical Cancer

What is a Pap smear?

HPV the silent killer, Prevention and diagnosis

Gynecologic Oncology Overview Staging updates and Soap Box Issues

CPC on Cervical Pathology

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Cervical Screening for Dysplasia and Cancer in Patients with HIV

TISSUE TUMOR MARKER EXPRESSION IN

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Vaginal intraepithelial neoplasia

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

HIV and AIDS Related Cancers DR GORDON AMBAYO UHS

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

Focus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Cervical cancer presentation

Case. Questions Diseases of the Genital System and the Breast

What is endometrial cancer?

Gynaecological Malignancies

Risk factors for precancerous lesions of the cervix in a population of Georgian women

What Causes Cervical Cancer? Symptoms of Cervical Cancer

I have no financial interests in any product I will discuss today.

Your Colposcopy Visit

Estimated New Cancers Cases 2003

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

CARCINOMA CERVIX. Dr. PREETHI REDDY. B. M S OBG II yr POST GRADUATE.

Proposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns

National Cervical Screening Program MBS Item Descriptors

Should Anal Pap Smears Be a Standard of Care in HIV Management?

4 Mousa Al-abbadi. Ola Al-juneidi. Abdul-rahman Ibrahim

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

CERVICAL CANCER FACTSHEET. What is cervical cancer?

Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University

Cervical Cancer : Pap smear

HPV, Cervical Dysplasia and Cancer

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Northern Ireland cervical screening programme. Information for primary care and smear takers

14. Cancer of the Cervix Uteri

I have no financial interests in any product I will discuss today.

HPV and Lower Genital Tract Disease. Simon Herrington University of Edinburgh, UK Royal Infirmary of Edinburgh, UK

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

Cervical Cancer Screening. David Quinlan December 2013

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Most common cancer Africans & Asians more prone because of poor socioeconomic condition Drastic decline in west as more detection of preinvasive

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

Female Reproduc.ve System. Kris.ne Kra7s, M.D.

Cytyc Corporation - Case Presentation Archive - July 2002

Update on Cervical Cancer Screening. Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014

Update on Cervical Cancer Screening

NHSCSP proposals for cervical screening intervals. Comments and recommendations of Council of the British Society for Clinical Cytology

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Cervical Cancer Prevention Month. January 2011 Morehouse College

I have no financial interests in any product I will discuss today.

Cervical Precancer: Evaluation and Management

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

Prevalence of human papillomavirus and Chlamydia trachomatis infection in paired urine and cervical smear samples of Palestinian young women.

Gynecological Cancers

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

Chapter 10: Pap Test Results

Pap plus HPV every 3 years with screening stopped at 65, 75 and 100 years; Pap plus HPV every 2 years with screening stopped at 65, 75 and 100 years.

HPV AND CERVICAL CANCER

HPV infections and potential outcomes

WHAT IS CERVICAL CANCER? Presented by Dr. Sylvia Deganus

PATIENT INFORMATION. about CERVICAL CANCER

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

PREVENTION OF CERVICAL CANCER

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

Validity of Colposcopy in the Diagnosis of Early Cervical Neoplasia. Dr. Olaniyan Olayinka Babafemi

Lauren O Sullivan, D.O. February 19, 2015

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Jacqui Morgan March 6, 2019

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Transcription:

Done by khozama jehad Neoplasia of the cervix

An overview of cervical neoplasia very import. Most tumors of the cervix are of epithelial origin and are caused by oncogenic strains of human papillomavirus (HPV) HPV, the causative agent of cervical neoplasia, has a tropism for the immature squamous cells of the transformation zone Most HPV infections are transient and are eliminated within months by an acute and chronic inflammatory response A subset of infections persists, however, and some of these progress to cervical intraepithelial neoplasia (CIN)

Cervical neoplasia, pathogenesis HPV is detectable by molecular methods in nearly all cases of CIN and cervical carcinoma Risk factors for CIN & invasive squamous cell carcinoma: 1- Related to HPV exposure: 2- Cigarette smoking 3- Human immunodeficiency virus especially in progression from CIN to cancer

Cervical neoplasia, pathogenesis cont d HPV infection occurs in the most immature squamous cells of the basal layer Replication of HPV DNA takes place in more differentiated overlying squamous cells squamous cells at this stage of maturation do not normally replicate DNA, but HPV-infected squamous cells do, as a consequence of expression of two potent HPV oncoproteins: E6 & E7

E6 & E7

Cervical neoplasia, pathogenesis cont d More recently, somatically acquired mutations in the tumor suppressor gene LKB1 were identified in more than 20% of cervical cancers

Cervical neoplasia, pathogenesis cont d

CIN (Cervical intraepithelial neoplasia) Usually precedes the development of an overt cancer by many years, sometimes decades CIN peaks in incidence at about 30 years of age, whereas invasive carcinoma peaks at about 45 years of age In many cases, even high-grade lesions fail to progress to cancer and may even regress the regression rate is much higher in low-grade lesions

CIN, cont d very importamt

Pap smear The most successful cancer screening test ever developed Cervical cancer no longer ranks among the top 10 causes of cancer deaths in U.S. women paradoxically, the incidence of CIN has increased to its present level of more than 50,000 cases annually. Increased detection has certainly contributed to this The recently introduced quadrivalent HPV vaccine for types 6, 11, 16, and 18 is very effective in preventing HPV infections but Pap smear is still needed, Why?

CIN, some management notes CIN is asymptomatic and comes to clinical attention through an abnormal Pap smear result Followed up by colposcopy, during which acetic acid is used to highlight the location of lesions and the areas to be biopsied LSIL: follow up (conservative management) HSIL: surgery (e.g., cone biopsy)

Invasive carcinoma of the cervix 1) 2) 3) Squamous cell carcinomas (75%) followed by: Adenocarcinomas and mixed adenosquamous carcinomas (20%) and small cell neuroendocrine carcinomas (less than 5%) All types are caused by HPV The relative proportion of adenocarcinomas has been increasing in recent decades

Cervical squamous cell carcinoma Peak incidence at the age of about 45 years Progression of CIN to invasive carcinoma is variable and unpredictable and requires HPV infection as well as mutations in genes such as LKB

Cervical squamous cell carcinoma, morphology 1) Range from microscopic foci of stromal invasion to grossly conspicuous exophytic tumors 2 3Barrel cervix when the tumor encircles the cervix and penetrates into the underlying stroma easily palpated The grading is based on squamous differentiation base on : ** The likelihood of spread to pelvic lymph nodes correlates with the depth of tumor invasion (less or more than 3mm) and the presence of tumor cells in vascular spaces **

Cervical squamous cell carcinoma, clinically: Symptoms especially appear in those who were not previously screened Vaginal bleeding e.g., postcoital bleeding Leukorrhea Painful coitus (dyspareunia) Dysuria Mortality is most strongly related to tumor stage Neuroendocrine carcinoma is bad Death in advanced disease is mainly due to direct invasion rather than metastasis, especially the invasion into bladder & ureter with resultant obstruction & renal failure